About Company
Founded in 1982, Parexel International has established itself as one of the largest clinical research organizations (CROs) in the world. The company offers a wide range of services, including regulatory consulting, clinical trial management, and market access strategies, aimed at expediting the drug approval process for its pharmaceutical and biotechnology clients. Parexel has played a crucial role in the development of approximately 95% of the top 200 best-selling biopharmaceuticals on the market today. With a strong emphasis on innovation and quality, Parexel operates globally, helping clients navigate complex regulatory environments and improve patient outcomes.